Saw Palmetto (Serenoa repens)

From the Native American Pharmacopoeia
Active Compounds
Benign Prostatic Hyperplasia
Mechanism of Action
Androgenic Alopecia (Hair Loss)
Other Uses
Forms and Preparations
Recommended Dosage
Cautions and Contraindications
Featured Videos

From the Native American Pharmacopoeia

Saw palmetto is a small, ground-level palm native to the southeastern coastal United States, particularly Florida, Georgia, and Alabama. Its dark purple-black ripe berries were a staple food and medicine for the Seminole, Calusa, and other indigenous peoples of the region. Native uses included support for urinary and reproductive function in men, treatment of wasting conditions, and as a general tonic.

European-American physicians adopted saw palmetto in the late 19th and early 20th centuries, and the berries were officially listed in the United States Pharmacopoeia from 1906 to 1916 and the National Formulary from 1926 to 1950. Use waned with the rise of pharmaceutical urology but resurged dramatically in the late 20th century after European clinical trials demonstrated efficacy in benign prostatic hyperplasia.

Today, saw palmetto is one of the most widely used botanical medicines in the world, with the standardized lipidosterolic extract (LSESr, Permixon) holding significant market share in European urology as a first-line agent for mild to moderate lower urinary tract symptoms.

Back to Table of Contents

Active Compounds

Saw palmetto's active fraction is a complex mixture of fatty acids and sterols extracted from the dried, ripe berry by hexane, ethanol, or supercritical CO2:

Free fatty acids -- predominantly lauric, oleic, myristic, and palmitic acids; the largest fraction of the lipidosterolic extract
Phytosterols -- including beta-sitosterol, campesterol, stigmasterol, and lupeol
Polyphenols -- including epicatechin and procyanidins
Flavonoids -- in the whole berry, with antioxidant activity

Standardization is critical. The lipidosterolic extract (typically 85-95% free fatty acids, 0.2-0.4% sterols) is the form used in clinical trials. Whole-berry powder, dried berry capsules, and aqueous extracts have not been shown to produce equivalent clinical effects and should not be assumed to be interchangeable. Permixon (Pierre Fabre) is the most-studied commercial preparation.

Back to Table of Contents

Benign Prostatic Hyperplasia

Saw palmetto's primary clinical application is the treatment of lower urinary tract symptoms associated with benign prostatic hyperplasia (BPH). Multiple randomized controlled trials have shown improvements in:

International Prostate Symptom Score (IPSS) -- typically reductions of 4-5 points on the 35-point scale
Maximum urinary flow rate -- modest improvements of 1-3 mL/sec
Nocturia (nighttime urination)
Post-void residual urine volume
Quality-of-life subscales

Effects are smaller than alpha-blockers (tamsulosin, alfuzosin) for symptom relief and smaller than 5-alpha-reductase inhibitors (finasteride, dutasteride) for prostate volume reduction, but saw palmetto has a much better tolerability profile -- particularly avoiding the sexual side effects (erectile dysfunction, decreased libido, retrograde ejaculation) that are common with pharmaceutical agents.

Saw palmetto is therefore most appropriate for men with mild to moderate BPH who prefer to avoid pharmaceutical side effects, or as an adjunct to lifestyle changes (caffeine reduction, evening fluid restriction, weight loss) before considering pharmaceutical therapy.

Back to Table of Contents

Mechanism of Action

Saw palmetto's effect on prostate symptoms appears to involve multiple mechanisms:

5-alpha-reductase inhibition -- partial inhibition of the enzyme that converts testosterone to dihydrotestosterone (DHT), the more potent androgen that drives prostate growth; effect is weaker than pharmaceutical 5-ARIs
Anti-inflammatory activity -- reduces inflammatory cytokines (IL-6, IL-8) and inflammatory infiltrate in prostate tissue
Anti-androgenic activity at the receptor level -- inhibits binding of DHT to androgen receptors in prostate cells
Smooth muscle relaxation -- mild alpha-1 adrenergic blocking activity, contributing to symptom relief
Apoptosis of prostate cells -- promotes programmed cell death in hyperplastic prostate tissue at therapeutic concentrations

Importantly, saw palmetto does not significantly affect serum PSA levels (unlike pharmaceutical 5-ARIs which lower PSA by approximately 50%). This is clinically relevant because PSA monitoring for prostate cancer screening remains accurate during saw palmetto use.

Back to Table of Contents

Androgenic Alopecia (Hair Loss)

Because saw palmetto inhibits 5-alpha-reductase -- the same enzyme target as pharmaceutical finasteride for male pattern hair loss -- there has been interest in using it for androgenic alopecia. Small clinical trials have shown modest improvements in hair count and patient satisfaction with topical or oral saw palmetto, though effects are smaller than pharmaceutical 5-ARIs.

Saw palmetto for hair loss is most appropriate for men seeking a milder, lower-side-effect alternative to finasteride. Topical preparations may produce local effects with even less systemic exposure.

Back to Table of Contents

Other Uses

Beyond the well-validated indications, saw palmetto has been studied for:

Chronic prostatitis / chronic pelvic pain syndrome -- modest evidence; often combined with stinging nettle and pygeum
Female androgenic alopecia, polycystic ovary syndrome, and hirsutism -- limited evidence; rationale based on 5-alpha-reductase inhibition
Sexual function -- mixed and inconsistent evidence; not a reliable libido or ED treatment

Back to Table of Contents

Forms and Preparations

Lipidosterolic extract (LSESr / Permixon) -- the form used in clinical trials; standardized to 85-95% fatty acids; the recommended form
Standardized softgel capsules -- 320 mg of LSESr in a single softgel; convenient daily dosing
Whole dried berry capsules -- traditional form; less reliable clinical effect
Tea -- minimal clinical relevance; the active compounds are lipid-soluble and poorly extracted by water
Topical preparations for hair loss -- typically 1-2% saw palmetto extract in a topical base

Back to Table of Contents

Recommended Dosage

For BPH symptoms -- 320 mg of LSESr daily, taken with food (improves absorption of fat-soluble extract); single dose or split as 160 mg twice daily
Onset -- expect 8-12 weeks for meaningful symptomatic improvement; do not abandon the trial too early
Duration -- safe for indefinite daily use; long-term safety established to at least 3-5 years
Combination protocols -- often combined with stinging nettle root, pumpkin seed extract, beta-sitosterol, and rye pollen for synergistic prostate support

Back to Table of Contents

Cautions and Contraindications

Always rule out prostate cancer -- BPH symptoms can mimic those of prostate cancer; obtain appropriate PSA and digital rectal examination evaluation before assuming benign disease
Anticoagulants and antiplatelets -- saw palmetto has mild antiplatelet activity; case reports of increased bleeding with warfarin, aspirin, and clopidogrel
Surgery -- discontinue at least two weeks before scheduled surgery due to bleeding risk
Pregnancy and breastfeeding -- not relevant for the typical user, but contraindicated due to anti-androgenic activity that could affect fetal development; do not use
Hormone-sensitive conditions -- caution in any condition where androgen modulation could be problematic; coordinate with endocrinology
GI side effects -- mild nausea, abdominal discomfort, or diarrhea in a small percentage of users; usually resolves with food
Headache, dizziness -- rare; usually mild and self-limited

Back to Table of Contents

Research Papers and References

The following PubMed search links provide curated entry points into the published clinical and mechanistic literature on Saw Palmetto (Serenoa repens). Each link opens directly in PubMed at the National Library of Medicine.

Serenoa repens for benign prostatic hyperplasia — PubMed: Serenoa repens BPH
Saw palmetto and 5-alpha reductase inhibition — PubMed: saw palmetto 5-alpha reductase
Saw palmetto IPSS symptom improvement — PubMed: saw palmetto IPSS
Permixon clinical trials prostate — PubMed: Permixon prostate
Saw palmetto and androgenic alopecia hair loss — PubMed: saw palmetto alopecia
Saw palmetto safety and PSA — PubMed: saw palmetto PSA safety
Saw palmetto polyphenol fatty acid composition — PubMed: saw palmetto fatty acid composition